BOZEN, Italy, August 24 /PRNewswire/ -- Health Robotics today reported that on the heels of its recent partnership announcement with McKesson, it has received categorical support from virtually all of its 13 North American customers in just a few days since the partnership was publicly announced. While several customers' hospital policies prevent them from publicly commenting on industry events, a few reactions to the McKesson-Health Robotics partnership [CytoCare Robot only] were cleared for publication.
"We have seen McKesson's announcement that it has become the exclusive North American strategic partner for Health Robotics' CytoCare, an Oncology I.V. Admixtures Robot implemented at our hospital in early 2008. We went "live" about a year ago and have since utilized CytoCare to prepare patient doses from as many as 60 different drug vials of antibiotic, chemotherapy, and/or monoclonal antibody therapies for Ampicillin, Busulfan, Carboplatin, Cisplatin, Cladribine, Cyclophosphamide, Cytarabine, Dacarbazine, Daunorubicin, Doxurubicin, Epirubicin, Etoposide, Fluororacil, Ganziclovir, Gemzar, Idarubicin, Ifosfamide, Irinotecan, Melphalan, Mesna, Methotrexate, Mitoxantrone, Oxaliplatin, Paclitaxel, Rituximab, Vinblastin, Vincristine, and Vinorelbine. CytoCare has filled patient doses with three different brands of 50ml to 1L i.v. Bags (Baxter Viaflex, B|Braun PAB, B|Braun Excel) and Becton Dickinson PlastiPak syringes in 3, 10, and 60cc sizes. The University of Colorado Hospital is a long-standing customer of McKesson Corporation, and looks forward to extending our relationship ever farther," stated Nancy Stolpman, Director of Pharmacy.
"We have been following the recent developments in I.V. robotics by
multiple start-up companies and have evaluated alternative technologies at
|SOURCE Health Robotics|
Copyright©2009 PR Newswire.
All rights reserved